On the apoptotic front, although protein-level assays were not conducted in this study, it is plausible that the increased apoptosis observed in HE-treated cells involves an elevated BAX/BCL-2 ratio, promoting mitochondrial outer membrane permeabilization and activation of the intrinsic apoptotic pathway [56]. The gene discussed is BAX; the disease is hereditary elliptocytosis.